ON-TRK

ON-TRK: PrOspective Non-interventional study in patients with locally advanced or metastatic TRK fusion cancer treated with larotrectinib

Study-ID: NCT04142437

DZL Disease Area: LC

Study Type: Interventional

DZL Role: DZL recruiting center

Funding: Externally - industry

DZL Participating Sites: CPC-M

Start Date: 03.04.2020

Completion Date: 31.03.2030

Status: Recruiting

Disease: SCLC/NSCLC

NCT Number: NCT04142437